Fig. 2From: Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLCImmunohistochemical expression of survivin and MUC1 in NSCLC [×10]. Survivin and MUC1 staining was carried out in the same NSCLC tumor biopsies. Survivin was expressed mainly in the cytoplasm, and MUC1 was mainly expressed in the membrane. a Patient 9 with squamous cell carcinoma. b Patient 1 with adenocarcinoma. Scale bar: 20 μmBack to article page